Table 3 Association between CMD and clinical risk factors
| Â | Univariate analysis OR (95% CI) | P value | Multivariate analysis OR (95% CI) | P value |
|---|---|---|---|---|
Age | 0.991 (0.971–1.010) | 0.352 |  |  |
Male | 0.979 (0.666–1.439) | 0.915 |  |  |
BMI | 1.130 (1.060–1.204) |  < 0.001 | 1.126 (1.051–1.206) | 0.001 |
Heart rate | 1.003 (0.987–1.020) | 0.714 |  |  |
Atrial fibrillation | 0.640 (0.268–1.531) | 0.316 |  |  |
Smoking | 0.988 (0.616–1.586) | 0.962 |  |  |
Hypertension | 0.843 (0.569–1.248) | 0.392 |  |  |
PCI performed | 0.624 (0.426–0.914) | 0.015 | 1.209 (0.625–2.338) | 0.573 |
Diabetes | 1.328 (0.892–1.979) | 0.162 |  |  |
CKD | 1.791 (0.836–3.835) | 0.134 |  |  |
CAD | 0.510 (0.343–0.760) | 0.001 | 0.557 (0.273–1.137) | 0.108 |
1-vessel disease | 0.803 (0.523–1.233) | 0.316 |  |  |
2-vessel disease | 0.791 (0.500–1.250) | 0.315 |  |  |
3-vessel disease | 0.540 (0.309–0.944) | 0.031 | 0.764 (0.416–1.403) | 0.385 |
TyG index | 1.629 (1.187–2.237) | 0.003 | 1.436 (1.014–2.034) | 0.042 |
TG | 1.204 (1.015–1.428) | 0.033 | – |  |
FBG | 1.140(1.012–1.284) | 0.031 | – |  |
HbA1c | 1.069 (0.905–1.263) | 0.435 |  |  |
CRP | 1.005 (0.976–1.034) | 0.749 |  |  |
Serum creatinine | 0.999 (0.990–1.009) | 0.908 |  |  |
TC | 1.225 (1.012–1.483) | 0.037 | 1.013 (0.687–1.493) | 0.947 |
LDL-C | 1.240 (0.997–1.542) | 0.053 | 1.109 (0.714–1.723) | 0.645 |
LVEF | 1.003 (0.972–1.035) | 0.840 |  |  |
Aspirin | 0.991 (0.655–1.498) | 0.964 |  |  |
Clopidogrel | 0.568 (0.386–0.835) | 0.004 | 0.702 (0.451–1.093) | 0.117 |
Statin | 0.662 (0.359–1.221) | 0.187 |  |  |
ACEI/ARB | 0.936 (0.641–1.368) | 0.733 |  |  |
Beta blocker | 0.916 (0.627–1.337) | 0.648 |  |  |
CCB | 1.111 (0.753–1.639) | 0.595 |  |  |